Hesdorffer M - Search Results

1

P16 loss and mitotic activity predict poor survival in patients with peritoneal malignant mesothelioma.

Borczuk AC, Taub RN, Hesdorffer M, Hibshoosh H, Chabot JA, Keohan ML, Alsberry R, Alexis D, Powell CA. Borczuk AC, et al. Among authors: hesdorffer m. Clin Cancer Res. 2005 May 1;11(9):3303-8. doi: 10.1158/1078-0432.CCR-04-1884. Clin Cancer Res. 2005. PMID: 15867227

2

Combined resection, intraperitoneal chemotherapy, and whole abdominal radiation for the treatment of malignant peritoneal mesothelioma.

Hesdorffer ME, Chabot JA, Keohan ML, Fountain K, Talbot S, Gabay M, Valentin C, Lee SM, Taub RN. Hesdorffer ME, et al. Am J Clin Oncol. 2008 Feb;31(1):49-54. doi: 10.1097/COC.0b013e3180684181. Am J Clin Oncol. 2008. PMID: 18376228 Clinical Trial.

3

Peritoneal mesothelioma.

Hesdorffer ME, Chabot J, DeRosa C, Taub R. Hesdorffer ME, et al. Curr Treat Options Oncol. 2008 Jun;9(2-3):180-90. doi: 10.1007/s11864-008-0072-2. Epub 2008 Oct 8. Curr Treat Options Oncol. 2008. PMID: 18841478 Review.

4

Molecular profiling of malignant peritoneal mesothelioma identifies the ubiquitin-proteasome pathway as a therapeutic target in poor prognosis tumors.

Borczuk AC, Cappellini GC, Kim HK, Hesdorffer M, Taub RN, Powell CA. Borczuk AC, et al. Among authors: hesdorffer m. Oncogene. 2007 Jan 25;26(4):610-7. doi: 10.1038/sj.onc.1209809. Epub 2006 Jul 24. Oncogene. 2007. PMID: 16862182

5

Two-stage operative cytoreduction and intraperitoneal chemotherapy for diffuse malignant peritoneal mesothelioma: Operative morbidity and mortality in phase I and II trials.

Kluger MD, Taub RN, Hesdorffer M, Jin Z, Chabot JA. Kluger MD, et al. Among authors: hesdorffer m. Eur J Surg Oncol. 2010 Oct;36(10):997-1003. doi: 10.1016/j.ejso.2010.07.001. Epub 2010 Aug 2. Eur J Surg Oncol. 2010. PMID: 20674253 Clinical Trial.

6

A phase II trial of temozolomide in patients with unresectable or metastatic soft tissue sarcoma.

Talbot SM, Keohan ML, Hesdorffer M, Orrico R, Bagiella E, Troxel AB, Taub RN. Talbot SM, et al. Among authors: hesdorffer m. Cancer. 2003 Nov 1;98(9):1942-6. doi: 10.1002/cncr.11730. Cancer. 2003. PMID: 14584078 Free article. Clinical Trial.

7

Approach to offering remote support to mesothelioma patients: the mesothelioma survivor project.

Bates GE, Hashmi AK, Bressler T, Zajac J, Hesdorffer M, Taub RN. Bates GE, et al. Among authors: hesdorffer m. Transl Lung Cancer Res. 2016 Jun;5(3):216-8. doi: 10.21037/tlcr.2016.05.05. Transl Lung Cancer Res. 2016. PMID: 27413697 Free PMC article.

8

The frequent expression of cancer/testis antigens provides opportunities for immunotherapeutic targeting of sarcoma.

Ayyoub M, Taub RN, Keohan ML, Hesdorffer M, Metthez G, Memeo L, Mansukhani M, Hibshoosh H, Hesdorffer CS, Valmori D. Ayyoub M, et al. Among authors: hesdorffer m, hesdorffer cs. Cancer Immun. 2004 Aug 9;4:7. Cancer Immun. 2004. PMID: 15298487

9

Phase II Study of Temozolomide and Thalidomide in Patients with Unresectable or Metastatic Leiomyosarcoma.

Boyar MS, Hesdorffer M, Keohan ML, Jin Z, Taub RN. Boyar MS, et al. Among authors: hesdorffer m. Sarcoma. 2008;2008:412503. doi: 10.1155/2008/412503. Epub 2008 Nov 16. Sarcoma. 2008. PMID: 19043564 Free PMC article.

10

Germline BAP1 Mutational Landscape of Asbestos-Exposed Malignant Mesothelioma Patients with Family History of Cancer.

Ohar JA, Cheung M, Talarchek J, Howard SE, Howard TD, Hesdorffer M, Peng H, Rauscher FJ, Testa JR. Ohar JA, et al. Among authors: hesdorffer m. Cancer Res. 2016 Jan 15;76(2):206-15. doi: 10.1158/0008-5472.CAN-15-0295. Epub 2015 Dec 30. Cancer Res. 2016. PMID: 26719535 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

25 results

Search Page

Filters